IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,253,466 | +4.9% | 292,184 | -5.1% | 0.51% | +5.6% |
| Q2 2023 | $12,636,830 | +9.7% | 307,990 | -4.4% | 0.48% | +8.5% |
| Q1 2023 | $11,518,323 | -4.5% | 322,281 | +1.0% | 0.45% | -13.4% |
| Q4 2022 | $12,055,202 | +69.0% | 319,174 | +97.9% | 0.52% | +57.0% |
| Q3 2022 | $7,132,000 | +3.3% | 161,246 | -13.5% | 0.33% | +17.1% |
| Q2 2022 | $6,903,000 | -10.5% | 186,454 | -10.4% | 0.28% | +3.7% |
| Q1 2022 | $7,710,000 | -36.6% | 208,158 | -47.9% | 0.27% | -30.4% |
| Q4 2021 | $12,153,000 | -18.6% | 399,392 | -10.2% | 0.39% | -13.2% |
| Q3 2021 | $14,921,000 | -18.0% | 444,887 | -2.5% | 0.45% | -19.3% |
| Q2 2021 | $18,199,000 | -8.2% | 456,226 | +3.4% | 0.55% | -11.4% |
| Q1 2021 | $19,830,000 | +2.3% | 441,054 | +28.7% | 0.62% | -4.9% |
| Q4 2020 | $19,381,000 | +18.8% | 342,774 | -0.3% | 0.66% | -1.8% |
| Q3 2020 | $16,320,000 | -18.8% | 343,952 | +0.9% | 0.67% | -23.6% |
| Q2 2020 | $20,099,000 | +21.9% | 340,900 | -2.3% | 0.88% | -3.5% |
| Q1 2020 | $16,493,000 | +0.5% | 348,834 | +28.5% | 0.91% | +31.8% |
| Q4 2019 | $16,406,000 | -5.3% | 271,568 | -6.1% | 0.69% | -8.3% |
| Q3 2019 | $17,326,000 | +50.8% | 289,198 | +61.7% | 0.75% | +41.2% |
| Q2 2019 | $11,492,000 | -40.4% | 178,814 | -24.8% | 0.53% | -40.2% |
| Q1 2019 | $19,290,000 | -32.5% | 237,645 | -55.0% | 0.89% | -35.0% |
| Q4 2018 | $28,558,000 | +5.6% | 528,259 | +0.8% | 1.37% | +11.8% |
| Q3 2018 | $27,039,000 | +24.4% | 524,218 | +0.5% | 1.22% | +42.5% |
| Q2 2018 | $21,731,000 | +11.5% | 521,515 | +18.0% | 0.86% | +9.1% |
| Q1 2018 | $19,489,000 | -16.6% | 442,125 | -4.8% | 0.79% | -12.2% |
| Q4 2017 | $23,367,000 | -23.8% | 464,560 | -23.1% | 0.90% | -22.8% |
| Q3 2017 | $30,646,000 | -10.8% | 604,455 | -10.5% | 1.16% | -6.5% |
| Q2 2017 | $34,342,000 | +6.6% | 675,088 | -15.8% | 1.24% | +13.3% |
| Q1 2017 | $32,215,000 | -26.9% | 801,376 | -13.0% | 1.10% | -33.0% |
| Q4 2016 | $44,060,000 | +16.4% | 921,174 | -10.9% | 1.63% | +18.0% |
| Q3 2016 | $37,867,000 | +18.6% | 1,033,481 | -24.6% | 1.38% | +53.5% |
| Q2 2016 | $31,939,000 | +27.6% | 1,371,376 | +121.9% | 0.90% | +28.9% |
| Q1 2016 | $25,024,000 | +94.5% | 617,886 | +197.4% | 0.70% | +109.6% |
| Q4 2015 | $12,866,000 | – | 207,757 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |